June 17, 2008 - Gamma Medica-Ideas and GE Healthcare entered a partnership allowing GE to be the exclusive distributor of Gamma Medica-Ideas’ pre-clinical imaging products effective July 1, 2008, hoping to have a positive impact on new pharmaceutical therapeutic development by allowing researchers to visualize the structure, function and response of laboratory animals in vivo.
The agreement complements GE Healthcare’s portfolio of pre-clinical products, and grants researchers greater access to GM-I’s innovative, fully-digital tri-modality positron emission tomography (PET); single photon emission computed tomography (SPECT) and computed tomography (CT) scanners.
Gamma Medica-Ideas have installed over 50 multimodality systems on four continents since 2002.
GE Healthcare currently offers dual-modality PET/CT, CZT based SPECT/CT and dedicated in-vivo and specimen pre-clinical CT scanners. The agreement with GM-I brings scaleable and upgradeable tri-modal (PET/SPECT/CT) systems under the GE umbrella.